D.E. Shaw & Co
PBMWW

D.E. Shaw & Co’s Psyence Biomedical Warrant PBMWW Stock Holding History

D.E. Shaw & Co’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.17K Hold
175,352
– – ﹤0.01% 4455
2025
Q4 		$3.45K Hold
175,352
– – ﹤0.01% 4534
2025
Q3 		$4.38K Hold
175,352
– – ﹤0.01% 4487
2025
Q2 		$3.54K Hold
175,352
– – ﹤0.01% 4285
2025
Q1 		$2.96K Hold
175,352
– – ﹤0.01% 4180
2024
Q4 		$2.16K Hold
175,352
– – ﹤0.01% 4331
2024
Q3 		$2.23K Hold
175,352
– – ﹤0.01% 4461
2024
Q2 		$1.86K Hold
175,352
– – ﹤0.01% 4406
2024
Q1 		$12.6K Buy
+175,352
New +$10.9K ﹤0.01% 4152

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return
SCM
Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return